Amneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled syringe autoinjector

Lupin received approval for its Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, from U.S. FDA

argenx SE announced it will regain worldwide rights to its anti-CD70 antibody cusatuzumab from Cilag GmbH International

U.S. FDA Accepts PharmaEssentia’s BLA Resubmission for ropeginterferon alfa-2b-njft for the Treatment of Polycythemia Vera

an additional indication related to central neuropathic pain (CNP) in Japan.

Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduction of proteinuria

Lupin announced the launch of its Digital Asthma Educator platform. The platform guides asthma patients on the correct technique of...

New data from patritumab deruxtecan demonstrated preliminary evidence of clinically meaningful and durable tumor response in patients

Mr Setu Doshi, Co-founder, Cure World Healthcare. In this Interview, Setu Doshi narrates his journey on setting up a marketing...

U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1